Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

University of Southampton patents new HIF inhibitors

June 13, 2022

Advisory board reviews preclinical data for fourth-generation EGFR TKI JIN-A02

June 10, 2022

Exscientia describes MALT1 inhibitors

June 10, 2022

New SERD inducers disclosed for treatment of cancer

June 10, 2022

MetasTx advances MTX-101 for prostate cancer and metastasis prevention

June 9, 2022

Qualigen Therapeutics initiates IND-enabling studies for QN-302

June 9, 2022

Ningbo Combireg Pharmaceutical Technology presents deuterated anticancer compounds

June 9, 2022

French researchers patent gold complexes and their use as antioxidants

June 9, 2022

CURACLE and collaborators patent carbazole derivative angiogenesis inhibitors

June 9, 2022

WNT plays dual role in melanoma spread to lung

June 8, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...